Previous close | 8.84 |
Open | 10.67 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 8.91 - 10.67 |
52-week range | 8.91 - 10.67 |
Volume | |
Avg. volume | N/A |
Market cap | 4.084M |
Beta (5Y monthly) | 0.94 |
PE ratio (TTM) | 0.03 |
EPS (TTM) | 2.97 |
Earnings date | 26 Apr 2023 - 01 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Emergent Biosolutions (EBS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Shares of Emergent BioSolutions (NYSE: EBS) were sinking 12.8% lower as of 10:53 a.m. ET on Friday. Fye also slashed the 12-month price target for Emergent BioSolutions from $23 to $9. Emergent BioSolutions certainly faces some challenges, though, that could justify investors' caution.
Emergent BioSolutions ( NYSE:EBS ) Full Year 2022 Results Key Financial Results Revenue: US$1.12b (down 38% from FY...